; (8) the FDA states, FDA encourages sponsors to consult with us if they wish to use a non-animal testing method they believe is suitable, adequate, validated, and feasible ; and (9) in some cases, drug manufacturers and sponsors have not been allowed by the FDA to use alternatives to animal testing to fulfill regulatory requirements, despite the FDA’s support for this technology in its industry guidance document. 3. Alternatives to animal tests Section 505 of the Federal Food, Drug and Cosmetic Act ( 21 U.S.C. 355 ) is amended by adding at the end the following new subsection: (z) Alternatives to animal tests The Secretary shall allow the sponsor of a drug to use a non-animal test as an alternative to an animal test for purposes of demonstrating the safety and effectiveness of a drug under this section if such approach satisfies the requirements of the applicable statutes and regulations. .